dc.creatorRodríguez, Juan Pablo
dc.creatorAstudillo, Pablo
dc.creatorRíos, Susana
dc.creatorSeitz, Germán
dc.creatorPino, Ana María
dc.date.accessioned2019-03-11T12:58:16Z
dc.date.available2019-03-11T12:58:16Z
dc.date.created2019-03-11T12:58:16Z
dc.date.issued2009
dc.identifierRevista Medica de Chile, Volumen 137, Issue 6, 2018, Pages 827-836
dc.identifier00349887
dc.identifier07176163
dc.identifierhttps://repositorio.uchile.cl/handle/2250/164851
dc.description.abstractMesenchymal stem cells (MSCs) found in bone marrow stroma, are able to differentiate into osteoblasts and adipocytes, among other cell phenotypes. In normal bone marrow balanced osteoblastic an adipocytic cell differentiation favours bone formation, while in osteoporosis there is an increased adipocyte content. Since osteoblasts and adipocytes originate from a common MSC precursor cell, here we discuss whether quantitative and qualitative stem cell defects may be the cause of alterations in the number and function of differentiated cells. This review analyzes some conditions that contribute to different osteogenic/adipogenic potentials in human bone marrow MSCs obtained from control and osteoporotic postmenopausal women. We analyze the protective effect exerted by locally generated factors like estradiol and leptin on MSCs differentiation, because altered bioavailability of these factors may play a role in osteoporosis. Osteoporotic MSCs (o-MSCs) are characterized by increased adipogen
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Medica de Chile
dc.subjectAdipogenesis
dc.subjectMesenchymal stem cells
dc.subjectOsteoporosis
dc.titleAdipogenesis and osteoporosis Adipogénesis y osteoporosis
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución